vs

Side-by-side financial comparison of AVITA Medical, Inc. (RCEL) and WINMARK CORP (WINA). Click either name above to swap in a different company.

WINMARK CORP is the larger business by last-quarter revenue ($21.1M vs $17.6M, roughly 1.2× AVITA Medical, Inc.). WINMARK CORP runs the higher net margin — 47.2% vs -66.0%, a 113.2% gap on every dollar of revenue. On growth, WINMARK CORP posted the faster year-over-year revenue change (7.9% vs -4.3%). WINMARK CORP produced more free cash flow last quarter ($8.5M vs $-6.1M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 2.4%).

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

Winmark Corporation is an American franchisor of five retail businesses that specialize in buying and selling used goods. The company is based in Minneapolis, Minnesota. Winmark was founded in 1988 as Play It Again Sports Franchise Corporation by Ron Olson and Jeffrey Dahlberg after they purchased the Play It Again Sports franchise rights from Martha Morris. They renamed the company to Grow Biz International Inc. in June 1993. Grow Biz went public in August 1993. In 2000, John Morgan replaced...

RCEL vs WINA — Head-to-Head

Bigger by revenue
WINA
WINA
1.2× larger
WINA
$21.1M
$17.6M
RCEL
Growing faster (revenue YoY)
WINA
WINA
+12.2% gap
WINA
7.9%
-4.3%
RCEL
Higher net margin
WINA
WINA
113.2% more per $
WINA
47.2%
-66.0%
RCEL
More free cash flow
WINA
WINA
$14.6M more FCF
WINA
$8.5M
$-6.1M
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
2.4%
WINA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RCEL
RCEL
WINA
WINA
Revenue
$17.6M
$21.1M
Net Profit
$-11.6M
$10.0M
Gross Margin
81.2%
Operating Margin
-59.1%
61.7%
Net Margin
-66.0%
47.2%
Revenue YoY
-4.3%
7.9%
Net Profit YoY
-0.3%
3.9%
EPS (diluted)
$-0.37
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RCEL
RCEL
WINA
WINA
Q4 25
$17.6M
$21.1M
Q3 25
$17.1M
$22.6M
Q2 25
$18.4M
$20.4M
Q1 25
$18.5M
$21.9M
Q4 24
$18.4M
$19.5M
Q3 24
$19.5M
$21.5M
Q2 24
$15.2M
$20.1M
Q1 24
$11.1M
$20.1M
Net Profit
RCEL
RCEL
WINA
WINA
Q4 25
$-11.6M
$10.0M
Q3 25
$-13.2M
$11.1M
Q2 25
$-9.9M
$10.6M
Q1 25
$-13.9M
$10.0M
Q4 24
$-11.6M
$9.6M
Q3 24
$-16.2M
$11.1M
Q2 24
$-15.4M
$10.4M
Q1 24
$-18.7M
$8.8M
Gross Margin
RCEL
RCEL
WINA
WINA
Q4 25
81.2%
Q3 25
81.3%
Q2 25
81.2%
Q1 25
84.7%
Q4 24
87.6%
Q3 24
83.7%
Q2 24
86.1%
Q1 24
86.4%
Operating Margin
RCEL
RCEL
WINA
WINA
Q4 25
-59.1%
61.7%
Q3 25
-53.6%
65.9%
Q2 25
-60.5%
64.0%
Q1 25
-63.9%
62.0%
Q4 24
-54.1%
65.3%
Q3 24
-70.6%
69.4%
Q2 24
-102.8%
64.7%
Q1 24
-155.0%
60.8%
Net Margin
RCEL
RCEL
WINA
WINA
Q4 25
-66.0%
47.2%
Q3 25
-77.3%
49.2%
Q2 25
-53.9%
51.9%
Q1 25
-74.9%
45.4%
Q4 24
-63.0%
49.0%
Q3 24
-82.9%
51.7%
Q2 24
-101.3%
51.8%
Q1 24
-168.0%
43.9%
EPS (diluted)
RCEL
RCEL
WINA
WINA
Q4 25
$-0.37
$2.68
Q3 25
$-0.46
$3.02
Q2 25
$-0.38
$2.89
Q1 25
$-0.53
$2.71
Q4 24
$-0.44
$2.60
Q3 24
$-0.62
$3.03
Q2 24
$-0.60
$2.85
Q1 24
$-0.73
$2.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RCEL
RCEL
WINA
WINA
Cash + ST InvestmentsLiquidity on hand
$18.2M
$10.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-16.6M
$-53.7M
Total Assets
$56.4M
$24.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RCEL
RCEL
WINA
WINA
Q4 25
$18.2M
$10.3M
Q3 25
$23.3M
$39.7M
Q2 25
$15.7M
$28.8M
Q1 25
$25.8M
$21.8M
Q4 24
$35.9M
$12.2M
Q3 24
$44.4M
$37.2M
Q2 24
$54.1M
$29.4M
Q1 24
$68.2M
$22.9M
Stockholders' Equity
RCEL
RCEL
WINA
WINA
Q4 25
$-16.6M
$-53.7M
Q3 25
$-6.7M
$-26.3M
Q2 25
$-12.9M
$-36.8M
Q1 25
$-4.6M
$-45.9M
Q4 24
$4.5M
$-51.0M
Q3 24
$12.2M
$-33.7M
Q2 24
$23.9M
$-42.2M
Q1 24
$32.6M
$-52.6M
Total Assets
RCEL
RCEL
WINA
WINA
Q4 25
$56.4M
$24.9M
Q3 25
$63.7M
$53.7M
Q2 25
$58.1M
$43.2M
Q1 25
$69.6M
$37.1M
Q4 24
$79.7M
$26.8M
Q3 24
$81.1M
$52.0M
Q2 24
$87.8M
$44.7M
Q1 24
$97.4M
$38.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RCEL
RCEL
WINA
WINA
Operating Cash FlowLast quarter
$-5.4M
$8.5M
Free Cash FlowOCF − Capex
$-6.1M
$8.5M
FCF MarginFCF / Revenue
-34.7%
40.3%
Capex IntensityCapex / Revenue
3.8%
0.1%
Cash ConversionOCF / Net Profit
0.86×
TTM Free Cash FlowTrailing 4 quarters
$-33.5M
$44.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RCEL
RCEL
WINA
WINA
Q4 25
$-5.4M
$8.5M
Q3 25
$-5.2M
$12.3M
Q2 25
$-10.2M
$9.0M
Q1 25
$-10.3M
$15.1M
Q4 24
$-8.1M
$8.5M
Q3 24
$-7.2M
$12.1M
Q2 24
$-12.8M
$8.2M
Q1 24
$-20.9M
$13.4M
Free Cash Flow
RCEL
RCEL
WINA
WINA
Q4 25
$-6.1M
$8.5M
Q3 25
$-6.2M
$12.2M
Q2 25
$-10.8M
$9.0M
Q1 25
$-10.5M
$15.0M
Q4 24
$-9.7M
Q3 24
$-11.0M
$12.1M
Q2 24
$-15.4M
$8.1M
Q1 24
$-22.0M
$13.3M
FCF Margin
RCEL
RCEL
WINA
WINA
Q4 25
-34.7%
40.3%
Q3 25
-36.1%
53.8%
Q2 25
-58.4%
44.0%
Q1 25
-56.9%
68.6%
Q4 24
-52.7%
Q3 24
-56.1%
56.3%
Q2 24
-101.6%
40.4%
Q1 24
-198.2%
66.0%
Capex Intensity
RCEL
RCEL
WINA
WINA
Q4 25
3.8%
0.1%
Q3 25
5.5%
0.3%
Q2 25
2.8%
0.3%
Q1 25
1.2%
0.2%
Q4 24
8.8%
0.0%
Q3 24
19.2%
0.0%
Q2 24
17.5%
0.5%
Q1 24
10.3%
0.4%
Cash Conversion
RCEL
RCEL
WINA
WINA
Q4 25
0.86×
Q3 25
1.10×
Q2 25
0.85×
Q1 25
1.51×
Q4 24
0.88×
Q3 24
1.09×
Q2 24
0.79×
Q1 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons